Scancell ModiFY Phase 1 Trial enters next stage
Scancell continue to make progress in their trialof ModiFY, dosing the first patient in Cohort 2.
Scancell continue to make progress in their trialof ModiFY, dosing the first patient in Cohort 2.
Arecor move to acquire Tetris Pharma Ltd to add key commercial diabetes product and build out Arecor’s specialty hospital products franchise.
Past performance is not indicative of future performance. Tax benefits depend on the individual circumstances of each investor and may be subject to change in the future. “Show us your business plan,” John Glencross, CEO and co-founder at private equity outfit Calculus Capital, advises UK independent production companies looking for Calculus investment. “We are interested … Continued
FIS has enhanced its wealth management solutions to include self-invested personal pension (SIPP) servicing in the U.K. with Quai Digital.
€3 million milestone payment triggered by pre-clinical progression for this Calculus portfolio company.
Francesca Rayneau, Director, Marketing and Investor Relations explores venture capital investing in recessionary conditions
Arvind Shandilya is an investment associate here at Calculus and recently we asked him some questions relating to his views on the industry, his role here and more about him!
Raindog Films, Calculus portfolio company, recently screened their new documentary ‘Hipgnosis’ ahead of its submission to major film festivals
Scancell to produce and clinically validate T cell redirecting bispecific antibodies, a promising new therapeutic to treat cancer.